Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1999
11/25/1999WO1999060167A1 Compositions and methods for topical delivery of oligonucleotides
11/25/1999WO1999060166A1 Compositions and methods for the pulmonary delivery of nucleic acids
11/25/1999WO1999060165A1 Chemically assembled nano-scale devices
11/25/1999WO1999060164A1 Mechanical stress induced genes, expression products therefrom, and uses thereof
11/25/1999WO1999060162A1 A novel method of diagnosing, monitoring, and staging prostate cancer
11/25/1999WO1999060160A1 A novel method of diagnosing, monitoring, and staging lung cancer
11/25/1999WO1999060153A2 Novel g-protein coupled receptor
11/25/1999WO1999060149A1 Co-precipitates of adenovirus with metal salts
11/25/1999WO1999060148A2 Display of viral proteins as ligands for cell-surface receptor
11/25/1999WO1999060147A2 Targeted delivery through a cationic amino acid transporter
11/25/1999WO1999060146A1 Adeno-associated virus vectors and uses thereof
11/25/1999WO1999060145A1 Mutant herpes simplex viruses and uses thereof
11/25/1999WO1999060144A1 Methods and compositions for producing viral particles
11/25/1999WO1999060143A1 Amphotropic retrovirus packaging cell line, process for its production and use thereof
11/25/1999WO1999060142A2 Gene therapy vectors and their use in antitumour therapy
11/25/1999WO1999060141A1 Genes and methods for control of nematodes in plants
11/25/1999WO1999060140A2 Geminivirus inducible promoter sequences and the uses thereof
11/25/1999WO1999060139A1 ENZYMATICALLY-ACTIVE RECOMBINANT HUMAN β-TRYPTASE AND METHOD OF MAKING SAME
11/25/1999WO1999060138A2 Regulated expression of pkc and/or srb1/psa1 in yeast
11/25/1999WO1999060137A2 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells
11/25/1999WO1999060136A1 Methods for producing polypeptides in filamentous fungal mutant cells
11/25/1999WO1999060135A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999WO1999060134A1 New peptide fragments for protein purification
11/25/1999WO1999060133A2 Human nucleic acid methylases
11/25/1999WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999WO1999060130A1 Expression of recombinant trypanosoma cruzi complement regulatory protein (crp)
11/25/1999WO1999060129A1 Methods and compositions for transgene identification
11/25/1999WO1999060128A1 Il-2 selective agonists and antagonists
11/25/1999WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999WO1999060126A2 Protein z-dependent protease inhibitor
11/25/1999WO1999060125A2 Secreted proteins
11/25/1999WO1999060124A2 Differentiation-associated sequences and methods of use therefor
11/25/1999WO1999060123A1 Methods and compositions for hdl holoparticle uptake receptor
11/25/1999WO1999060122A1 Method for examining central nervous system diseases and method for screening remedies
11/25/1999WO1999060121A1 Metabotropic glutamate receptor-like protein and encoding cdna
11/25/1999WO1999060120A2 Soluble t cell receptor
11/25/1999WO1999060119A2 Multivalent t cell receptor complexes
11/25/1999WO1999060118A1 GABAA RECEPTOR ε2 SUBUNIT
11/25/1999WO1999060117A2 Prax-1 polypeptide
11/25/1999WO1999060116A1 Nucleic acid encoding protein, down-regulated in metastasis (drim), and its diagnostic and therapeutic use
11/25/1999WO1999060115A2 Proteins and genes useful as tumor markers
11/25/1999WO1999060113A1 Novel method for isolating gene
11/25/1999WO1999060111A1 Genetics-assisted target evaluation in antibacterial drug discovery
11/25/1999WO1999060110A2 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
11/25/1999WO1999060109A2 Soybean gene promoters
11/25/1999WO1999060108A2 Transgenic animals produced by homologous sequence targeting
11/25/1999WO1999060107A2 Nicotianamine synthase genes, isolation and use thereof
11/25/1999WO1999060106A2 A universal plant promoter inducible by low- temperatures
11/25/1999WO1999060104A1 Novel glutaminase, gene thereof and process for producing the same
11/25/1999WO1999060103A2 Galactosyltransferase from plants involved in galactomannan biosynthrsis
11/25/1999WO1999060102A2 Improved in vivo production of cephalosporins
11/25/1999WO1999060100A1 Irak modified transgenic animals
11/25/1999WO1999060099A1 Amino acid modified polypeptides
11/25/1999WO1999060097A1 clpX OF $i(STREPTOCOCCUS PNEUMONIAE)
11/25/1999WO1999060096A2 Oxygenase enzymes and screening method
11/25/1999WO1999060025A1 Gene recombinant antibodies
11/25/1999WO1999060024A1 Methods for amyloid removal using anti-amyloid antibodies
11/25/1999WO1999060021A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060019A1 HUMAN EDG3sb GENE
11/25/1999WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999WO1999060014A2 Methods and compounds for modulating nuclear receptor coactivator binding
11/25/1999WO1999060013A2 Il-6 antagonist peptides
11/25/1999WO1999060012A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999WO1999060011A1 Secretion of toxins by gram-negative bacteria
11/25/1999WO1999060010A1 Compositions and methods for the pulmonary delivery of nucleic acids
11/25/1999WO1999060008A1 Cytosine deaminase gene
11/25/1999WO1999060007A2 Libraries of oligomers labelled with different tags
11/25/1999WO1999060005A1 Method and device for purifying nucleic acids
11/25/1999WO1999059638A2 Compositions and methods for the delivery of nucleic acid molecules
11/25/1999WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
11/25/1999WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999WO1999059629A1 Humanized antibodies that recognize verotoxin ii and cell line producing same
11/25/1999WO1999059625A1 Vaccine delivery system
11/25/1999WO1999059624A2 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia
11/25/1999WO1999059620A1 Angiostatin receptor
11/25/1999WO1999059619A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999WO1999059562A2 Method of treating or preventing abnormal cardiac cell growth by inhibiting the 12-lipoxygenase pathway
11/25/1999WO1999059547A1 Long-circulating liposomal compositions
11/25/1999WO1999059546A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
11/25/1999WO1999050301A3 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
11/25/1999WO1999050298A9 GFRα-X, A NOVEL GLIAL-DERIVED NEUROTROPHIC FACTOR RECEPTOR AND USES THEREFOR
11/25/1999WO1999049079A9 Rolling circle replication of padlock probes
11/25/1999WO1999049024A3 Methods and compositions for production of multimeric proteins in transgenic plants
11/25/1999WO1999049020A3 Phenol oxidizing enzyme enzymes
11/25/1999WO1999048507A3 Steroidal saponins for treating alzheimer's disease
11/25/1999WO1999047689A3 Inhibitors of apoptosis proteins in plants
11/25/1999WO1999047679A3 Genetic engineering salt tolerance in crop plants
11/25/1999WO1999047656A3 Nucleic acid binding proteins
11/25/1999WO1999046592A9 Regulation of the cell cycle by sterols
11/25/1999WO1999045155A9 Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid
11/25/1999WO1999045103A3 Human spinal cord cell lines and methods of use therefor
11/25/1999WO1999043835A3 Methods for producing a polypeptide in a bacillus cell
11/25/1999WO1999043832A3 Human proteinase molecules
11/25/1999WO1999043815A3 Human monoclonal antibodies capable of oligospecifically recognizing the major tumor-associated gangliosides and methods of use thereof
11/25/1999WO1999043808A8 Human c-maf compositions and methods of use thereof
11/25/1999WO1999042834A3 Treating cancer
11/25/1999WO1999041390A3 Expression vector for the production of dead proteins
1 ... 3320 3321 3322 3323 3324 3325 3326 3327 3328 3329 3330 3331 3332 3333 3334 3335 3336 3337 3338 3339 3340 ... 4023